| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |